Beisiegel U (1998) Lipoprotein metabolism. Eur Heart J 19(Suppl A):S20–S23
Google Scholar
Frank PG, Marcel YL (2000) Apolipoprotein A-I: structure-function relationships. J Lipid Res 41:853–872
CAS
PubMed
Google Scholar
Packard CJ, Shepherd J (1997) Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol 17:3542–3556
Article
CAS
Google Scholar
Rifai N, Bachorik PS, Alberts JJ (1999) Lipids, lipoproteins, and apolipoproteins. In: Burtis CA, Ashwood ER (eds) Tietz - textbook of clinical chemistry, 3rd edn. Saunders, Philadelphia, pp 809–861
Google Scholar
Walldius G, Jungner I (2006) The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy – a review of the evidence. J Intern Med 259:493–519
Article
CAS
Google Scholar
McQueen MJ, Hawken S, Wang X, INTERHEART Study Investigators (2008) Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 372:224–233
Article
CAS
Google Scholar
Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358:2026–2033
Article
CAS
Google Scholar
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–952
Article
Google Scholar
Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J (2009) Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302:1993–2000
Article
Google Scholar
Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I, Walldius G (2003) Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 361:777–780
Article
CAS
Google Scholar
Pfohl M, Schreiber I, Liebich HM, Häring HU, Hoffmeister HM (1999) Upregulation of cholesterol synthesis after acute myocardial infarction–is cholesterol a positive acute phase reactant? Atherosclerosis 142:389–393
Article
CAS
Google Scholar
Anderson JL, Adams CD, Antman EM et al (2013) for American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 127(23):e663–e828
PubMed
Google Scholar
American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542
Article
Google Scholar
Knudsen AS, Darwish AZ, NØrgaard A, Gøtzsche O, Thygesen K (1998) Time course of myocardial viability after acute myocardial infarction: an echocardiographic study. Am Heart J 135:51–57
Article
CAS
Google Scholar
Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation. 2001; 103:3019–41.
Article
Google Scholar
Krintus M, Kozinski M, Stefanska A, Sawicki M, Obonska K, Fabiszak T, Kubica J, Sypniewska G (2012) Value of C-reactive protein as a risk factor for acute coronary syndrome: a comparison with apolipoprotein concentrations and lipid profile. Mediators Inflamm 2012:419804
Article
Google Scholar
Vaverkova H, Karasek D, Novotny D, Jackuliakova D, Lukes J, Halenka M, Frohlich J (2009) Apolipoprotein B versus LDL-cholesterol: association with other risk factors for atherosclerosis. Clin Biochem 42:1246–1251
Article
CAS
Google Scholar
Sypniewska G, Bergmann K, Krintus M. How do apolipoproteins ApoB and ApoA-I perform in patients with acute coronary syndromes. Journal of Medical Biochemistry De Gruyter Open Sp. z o.o.; 30(3). Available from: https://doi.org/10.2478/v10011-011-0022-6.
Article
CAS
Google Scholar
Marcovina SM, Alberts JJ, Henderson LO, Hannon WH (1993) International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material. Clin Chem 39:773–781
Article
CAS
Google Scholar
Marcovina S, Packard J (2006) Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Intern Med 259:437–446
Article
CAS
Google Scholar
Talmud PJ, Hawe E, Miller GJ, Humphries SE (2002) Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler Thromb Vasc Biol 22:1918–1923
Article
CAS
Google Scholar
Tani S, Nagao K, Anazawa T, Kawamata H, Furuya S, Takahashi H, Iida K, Matsumoto M, Washio T, Kumabe N, Hirayama A (2010) Relation of change in apolipoprotein B/apolipoprotein A-I ratio to coronary plaque regression after Pravastatin treatment in patients with coronary artery disease. Am J Cardiol 105:144–148
Article
CAS
Google Scholar
Meisinger C, Loewel H, Mraz W, Koenig W (2005) Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study. Eur Heart J 26:271–278
Article
CAS
Google Scholar
Westerveld HT, van Lennep JE, van Lennep HW, Liem AH, de Boo JA, van der Schouw YT, Erkelens DW (1998) Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography. Arterioscler Thromb Vasc Biol 18:1101–1107
Article
CAS
Google Scholar
Luc G, Bard JM, Ferrières J, Evans A, Amouyel P, Arveiler D, Fruchart JC, Ducimetière P (2002) Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease. The PRIME Study. Arterioscler Thromb Vasc Biol 22:1155–1161
Article
CAS
Google Scholar
Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD (2004) The apoB/apoA-I ratio is better than cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 42:1355–1363
Article
CAS
Google Scholar
Walldius G, Jungner I (2004) Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Intern Med 255:188–205
Article
CAS
Google Scholar
Ballantyne CM, Andrews TC, Kramer JH, ACCESS study Group Atorvastatin Comparative cholesterol Efficacy and Safety Study. Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzime A reductase inhibitors on non-high- density lipoprotein cholesterol levels. Am J Cardiol 2001; 88: 265-269.
Endreas M (2005) Statins and stroke. J Cereb Blood Flow Metab 25:1093–1110
Article
Google Scholar
Charlton-Menys V, Durrington P (2006) Apolipoproteins AI and B as therapeutic targets. J Intern Med 259:462–472
Article
CAS
Google Scholar
Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB (2005) Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 353:46–57
Article
CAS
Google Scholar